Emisjoner, børsnoteringer m.m.

Wilson Therapeutics AB

(29.04.2016) DNB Markets is acting as Joint Global Coordinator and Joint Bookrunner in relation to the initial public offering of Wilson Therapeutics AB (publ) (“Wilson Therapeutics” or the ”Company”) and the related listing on Nasdaq Stockholm.